Target Therapy With Vaccinia Virus Harboring IL-24 For Human Breast Cancer

Conclusions: Our findings provided documentation that VG9-IL-24 was targeted in vitro and exhibited enhanced antitumor effects, and it may be an innovative therapy for breast cancer.

Source: Journal of Cancer - July 2, 2020 Category: Cancer & Oncology Authors: Lili Deng, Jun Fan, Yuedi Ding, Xue Yang, Biao Huang, Zhigang Hu Tags: Research Paper Source Type: research